JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Synthesis and Imaging of Novel CDK19-Targeted Tracers Incorporating an Albumin-Binding Moiety

  • 0Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Journal of Labelled Compounds & Radiopharmaceuticals +

|

March 13, 2025

|

March 13, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Albumin-based radiotracers show promise for prostate cancer diagnosis and treatment. This strategy enhances tissue uptake and retention of large polarity tracers, aiding drug optimization.

Area Of Science

  • Radiopharmaceutical chemistry
  • Molecular imaging
  • Oncology

Background

  • Cyclin-dependent kinase 19 (CDK19) is a validated target for prostate cancer diagnostics and therapeutics.
  • Existing CDK19-targeted PET tracers possess large polarity, hindering optimal physiochemical properties for clinical application.
  • Drug optimization is crucial to enhance the efficacy of these tracers.

Purpose Of The Study

  • To develop and evaluate novel albumin-based radiotracers for CDK19 targeting in prostate cancer.
  • To investigate the impact of albumin conjugation on the physicochemical properties and in vivo performance of PET tracers.
  • To assess the potential of the albumin strategy for optimizing radiopharmaceuticals.

Main Methods

  • Synthesis of two novel Gallium-68 (<sup>68</sup>Ga) labeled tracers, <sup>68</sup>Ga-IRM-14a and <sup>68</sup>Ga-IRM-14b, utilizing an albumin-binding strategy.
  • In vivo microPET imaging studies in mice models to evaluate biodistribution, tissue uptake, and retention.
  • Analysis of physicochemical property modifications induced by albumin conjugation.

Main Results

  • The synthesized albumin-based tracers, <sup>68</sup>Ga-IRM-14a and <sup>68</sup>Ga-IRM-14b, demonstrated altered physicochemical properties compared to non-conjugated analogs.
  • In vivo studies revealed significantly increased tissue uptake and retention of the albumin-conjugated tracers.
  • The albumin moiety effectively improved the characteristics of the large polarity tracers.

Conclusions

  • The albumin strategy represents a significant advancement in optimizing large polarity radiotracers for CDK19-targeted PET imaging.
  • This approach enhances tracer tissue uptake and retention, offering benefits for future prostate cancer diagnosis and therapy.
  • Albumin conjugation is a valuable tool for improving radiopharmaceutical properties in molecular imaging.

Keywords: